Content deleted Content added
GreenC bot (talk | contribs) m 1 archive template merged to {{webarchive}} (WAM) |
m →Database structure: clean up, replaced: withiin → within using AWB |
||
Line 27:
# The second type of BIND entries are the molecular complexes. Molecular complexes are defined as an aggregate of molecules that are stable and have a function when bound to each other. The record may also contain some information on the role of the complex in various interactions and the molecular complex entry links data from 2 or more interaction records.
# The third component of BIND is the pathway record section. A pathway consists of a network of interactions that are involved in the regulation of cellular processes. This section may also contain information on phenotypes and diseases related to the pathway.
<br />The minimum amount of information needed to create an entry in BIND is a [[PubMed]] publication reference and an entry in another database (e.g. [[GenBank]]). Each entry
BIND is based on a data specification written using Abstract Syntax Notation 1 ([[ASN.1]]) language. ASN.1 is used also by [[National Center for Biotechnology Information|NCBI]] when storing data for their [[Entrez]] system and because of this BIND uses the same standards as NCBI for data representation. The ASN.1 language is preferred because it can be easily translated into other data specification languages (e.g. [[XML]]), can easily handle complex data and can be applied to all biological interactions – not just proteins.<ref name= "BIND, 2001"/> Bader and Hogue (2000) have prepared a detailed manuscript on the ASN.1 data specification used by BIND.<ref name= "BIND, 2000">Bader, GD, Hogue, CWV. BIND- a data specification for storing and describing biomolecular interactions, molecular complexes and pathways. ''Bioinformatics'' 16(5): 465-477 (2000).</ref>
| |||